Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
The cannabis clinical scrutiny embraced by industry leaders marks a pivotal shift toward transparency and patient safety. This approach ensures clinicians have reliable data for evidence-based prescribing decisions. Cannabis clinical scrutiny benefits…
Exploring Cannabis Transcriptomic and Cellular Responses via Dual RNA Sequencing
Dual RNA sequencing cannabis research reveals detailed transcriptomic responses in Cannabis sativa. This molecular research helps clarify how genetics and environment influence cannabinoid production. Understanding these responses is key to improving…
Happy Cannabis in Rockford Reopens with New Ownership and Expanded Products
Dispensary ownership changes can significantly impact patient access to consistent cannabis products. This is especially important for patients with established cannabinoid regimens. The reopening of Happy Cannabis in Rockford highlights these clinical…
Dr. Oz CBD Gummies: Can They Really Help You Sleep Better And Regrow Hair? Let’s Get Real.
Celebrity-endorsed CBD products often make bold claims about sleep improvement and hair regrowth. However, these claims lack strong clinical evidence and can mislead patients. Clinicians should guide patients toward evidence-based cannabis therapeutics…
Texas Hemp Industry Hopeful to Continue Operation Amid THC Ban Pause
Texas hemp industry regulation is currently in a state of flux due to a pause on the THC ban. This pause affects patient access to hemp-derived cannabinoid products used for medical purposes. Clinicians should monitor these regulatory changes closely for…
New Lawsuit Challenges Texas Hemp Licensing and THC Measurement Rules
The 2026 Texas hemp regulations lawsuit targets licensing and THC measurement standards. This dispute affects product quality and patient safety in the hemp industry. Clinicians should monitor these regulatory changes closely.
Clinical Insights on the Cannabis Wellness Expo 2026
The cannabis wellness expo 2026 offers a unique blend of licensed products and wellness claims that clinicians should evaluate carefully. Patients attending the expo may have questions about new products and delivery methods. Clinicians must guide…
EU Continues Scrutiny on CBD Novel Food Applications
CBD regulatory uncertainty in the EU continues as six more novel food applications are rejected. This impacts patient access to standardized CBD products and complicates clinical recommendations. Understanding these regulatory challenges is essential for…
Are Makers CBD Gummies Legit? Evaluating Product Claims and Scientific Evidence
CBD gummy product quality varies widely across manufacturers, impacting safety and efficacy. Evaluating product claims and scientific evidence is crucial for patient safety. This article discusses key factors in assessing CBD gummy product quality.
How Northern Ontario Researchers Use Bacteria-Powered Tech for Cannabis Extraction
Northern Ontario researchers are pioneering bacteria-powered cannabis extraction techniques. These novel methods could enhance product quality and consistency in medical cannabis. Understanding bacteria-powered cannabis extraction helps clinicians…